The Centre today said it would soon frame a law to prevent government doctors from receiving gifts and cash from pharmaceutical companies.
“Doctors take favours from pharma companies either in the form of cash or in kind and in return give unnecessary favour to them...They prescribe costly medicines of that company...To stop this, the Centre has decided to formulate a law and implement it soon,” Union Health and Family Welfare Minister Gulam Nabi Azad said at a Nationalistic Doctor’s Forum programme.
Azad said the Centre would set up an AIIMS-like institute in West Bengal soon and the state government has already agreed to allot 100-acre land for the purpose.
The Union government has sanctioned Rs 890 crore for the 960-bed hospital with super-speciality facility, he said.
A central fund of Rs 140 crore has also been sanctioned for upgrading Calcutta Medical College and Hospital.
He said the Centre has also decided to go in for a private-public partnership to accelerate and improve the healthcare system of the country.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app